GlassScriptPhysician profile
Kelli Stewart
NPI 1235781766
$3,292.19
in general payments reported to CMS, 2019-2025
33 companies · $786 in 2025
The $786 reported for 2025 was more than what 81% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $942 · 2023: $708 · 2024: $857 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,350.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $688.73 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $555.24 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $267.26 | 2021-2025 | |
| Pfizer INC. | $182.21 | 2021-2025 | |
| Lilly USA, LLC | $159.52 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $140.00 | 2021-2024 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $135.95 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $113.23 | 2021-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceuticals, INC. | $104.56 | 2021 | |
| Idorsia Pharmaceuticals US INC | $95.73 | 2023-2024 | Quviviq |
| Phathom Pharmaceuticals, INC. | $95.71 | 2024-2025 | Voquezna |
| Amgen INC. | $75.84 | 2021-2025 | Otezla, Repatha, Repatha |
| Dexcom, INC. | $70.67 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $66.66 | 2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $55.72 | 2023-2025 | Rexulti |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $47.37 | 2025 | Korlym |
| Janssen Pharmaceuticals, INC | $44.70 | 2024 | Spravato |
| Eisai INC. | $39.89 | 2021-2025 | |
| Corium, LLC | $39.86 | 2021-2023 | Azstarys |
| Lundbeck LLC | $35.82 | 2024-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $31.91 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.24 | 2021 | |
| Seqirus USA INC | $24.43 | 2025 | Fluad, Flucelvax |
| Axsome Therapeutics, INC. | $24.37 | 2024 | Auvelity |
| Ucb, INC. | $23.88 | 2021 | |
| Forte Bio-Pharma LLC | $22.23 | 2023 | Prolate, Nalocet |
| Optinose US, INC. | $21.22 | 2021 | |
| Boston Scientific Corporation | $19.30 | 2025 | Watchman Access System |
| Ironshore Pharmaceuticals INC. | $18.46 | 2023 | Jornay Pm |
| Adlon Therapeutics L.P. | $16.40 | 2021 | |
| Exact Sciences Corporation | $15.10 | 2023 | Cologuard Collection Kit |
| Genentech USA, INC. | $14.63 | 2021 | |
| Amarin Pharma, INC. | $14.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.